Clinical Trials Sponsored by Mentis Cura

Total 5086 results

Landspitali University Hospital
Mentis Cura

Unknown

EEG-cholinergic Index and Clinical Response to Treatment With Cholinesterase Inhibitors (Cholindex)

Alzheimer´s Disease
Mentis Cura
Landspitali University Hospital

Unknown

EEG Classification System for Dementia

Dementia
Mentis Cura
Landspitali University Hospital

Completed

The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study

AD
Mentis Cura
The Icelandic Center for Research

Completed

Intra-individual Stability in Electroencephalography (EEG) Parameters

Stability of EEG Features in Humans
Cura Biotech LLC

Unknown

A Study Evaluating the Safety and Efficacy of Cura-100 in Subjects With Rheumatoid Arthritis and Osteoarthritis

Osteoarthritis | Rheumatoid Arthritis

United States
Casa di Cura Dott. Pederzoli

Unknown

3D Laparoscopy Versus 2D Laparoscopy (Lap3D)

Colorectal Cancer | Inflammatory Bowel Disease

Italy
University of Michigan
Cura Surgical

Terminated

Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section

Obesity | Complications; Caesarean Section, Wound

United States
Nura Medical

Not yet recruiting

Testing of Medication Dosing Software

Pediatric Emergency Medicine
Aura Biosciences

Recruiting

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma (CoMpass)

Ocular Melanoma | Uveal Melanoma | Choroidal Melanoma | Indeterminate Lesions

United States
Cure CMD

Recruiting

Congenital Muscle Disease Study of Patient and Family Reported Medical Information (CMDPROS)

Emery-Dreifuss Muscular Dystrophy | Congenital Myasthenic Syndrome | Limb-Girdle Muscular Dystrophy | Congenital Muscular Dystrophy With ITGA7 (Integrin Alpha-7) Deficiency | Alpha-Dystroglycanopathy (Congenital Muscular Dystrophy and Abnormal Glycosylation of Dystroglycan With Severe Epilepsy) and other conditions

United States
AURA Paris

Completed

Immune Response Following COVID-19 in Hemodialysis Patients (IMMUNOVIDIAL)

COVID-19 | Cytokine Storm | Dialysis; Complications

France
Cure Therapeutics

Unknown

Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow

Tendonitis

Poland
Aura Biosciences

Recruiting

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Muscle-Invasive Bladder Carcinoma | Non-muscle-invasive Bladder Cancer

United States
Aura Biosciences

Recruiting

A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma

Choroidal Melanoma | Indeterminate Lesions of Eye

United States
Aura Biosciences

Completed

Study in Subjects With Small Primary Choroidal Melanoma

Ocular Melanoma | Uveal Melanoma | Choroidal Melanoma

United States
Aura Biosciences

Active, not recruiting

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Ocular Melanoma | Uveal Melanoma | Choroidal Melanoma

United States
Aura Biosciences

Terminated

Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM) (IL)

Choroidal Melanoma | Indeterminate Lesions

United States
AURA Sante

Unknown

Long Term Physical Activity for Hemodialysis Patients

End Stage Renal Disease on Hemodialysis
Casa di Cura Privata Villa Mafalda

Recruiting

Desogestrel Versus GnRH Antagonist in IVF/ICSI (DEGOS)

Infertility | IVF

Italy
Casa Di Cura Villa Serena SpA

Completed

Measurements of Diaphragmatic Mobility on COPD Patients

Pulmonary Disease, Chronic Obstructive

Italy
Casa di Cura Privata Villa Mafalda

Unknown

The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles (PPOS)

Infertility | IVF

Italy
Casa di Cura Privata del Policlinico SpA

Completed

Mirror Therapy Efficacy in Upper Limb Rehabilitation Early After Stroke (MT)

Stroke, Acute
Cara Therapeutics, Inc.

Recruiting

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica

Pruritus | Notalgia Paresthetica

United States, Poland, Spain, Canada, Germany
Kura Oncology, Inc.

Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, or 7+3 in Patients With AML

Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Myeloid Sarcoma | Acute Myeloid Leukemia Recurrent | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute Leukemia | Refractory AML | NPM1 Mutation | Mixed Lineage Leukemia Gene Mutation | AML With Mutated NPM1 | KMT2Ar

United States
Cara Therapeutics, Inc.

Recruiting

A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States
Kura Oncology, Inc.

Recruiting

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Acute Myeloid Leukemia | Acute Leukemia of Ambiguous Lineage | Advanced Malignant Neoplasm | Mixed Phenotype Acute Leukemia | Mixed Lineage Leukemia | Mixed Lineage Acute Leukemia

United States, Spain, United Kingdom, France, Germany, Canada, Belgium, Italy
Kura Oncology, Inc.

Available

Expanded Access to Ziftomenib

Acute Lymphoblastic Leukemia, With Appropriate Mutations | Acute Myeloid Leukemia, With NPM1 Mutations
Cara Therapeutics, Inc.

Terminated

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin as Adjunct Therapy to a Topical Corticosteroid for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KIND-1)

Pruritus | Atopic Dermatitis

United States
Cara Therapeutics, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States
Kura Oncology, Inc.

Terminated

Cardiovascular Safety Study of Tipifarnib in Patients With Advanced Solid Malignancies

Advanced Solid Tumor

United States
Cara Therapeutics, Inc.

Terminated

Study to Evaluate the Safety and Efficacy of Oral CR845 (Difelikefalin) in Patients With Primary Biliary Cholangitis (PBC) and Moderate-to-Severe Pruritus

Cholestatic Pruritus

United States
Cara Therapeutics, Inc.

Completed

A Study to Evaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)

Uremic Pruritus

United States
Cara Therapeutics, Inc.

Completed

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis (KARE)

Pruritus | Atopic Dermatitis

United States, Canada
Kura Oncology, Inc.

Terminated

First-in-Human Study of KO-947 in Non-Hematological Malignancies

Advanced Malignant Neoplasm

United States, Spain
Kura Oncology, Inc.

Completed

Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS Mutations

Thyroid Cancer | Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | HRAS Mutant Tumor | Other Squamous Cell Carcinoma (SCC) With HRAS Mutant Tumor

Spain, United States, Korea, Republic of, France, Belgium, Germany, Greece, Italy, Netherlands, United Kingdom
Kura Oncology, Inc.

Completed

Investigation of Tipifarnib in Treatment of Subjects With PTCL That Have Not Responded to Standard Therapy. (PTCL)

Relapsed or Refractory Peripheral T-Cell Lymphoma

United States, Spain, Korea, Republic of
Cara Therapeutics, Inc.

Completed

A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee

Arthritis | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Osteoarthritis, Knee | Osteoarthritis, Hip

United States
Cara Therapeutics, Inc.

Completed

Study to Investigate the Effects of Single Intravenous Doses of Difelikefalin (CR845) on the QTc Interval in Healthy Subjects

Healthy

United States
Kura Oncology, Inc.

Terminated

Tipifarnib in Subjects With Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Acura Pharmaceuticals Inc.

Completed

Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users

Opioid-Related Disorders

United States
Cara Therapeutics, Inc.

Completed

A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee

Osteoarthritis

United States
Cara Therapeutics, Inc.

Completed

Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus

Pruritus | Uremic Pruritus

United States
Cara Therapeutics, Inc.

Completed

Study to Evaluate Analgesic Effect of Intravenous Administration of Kappa Agonist CR845 After Hysterectomy Surgery

Acute Pain

United States
Cara Therapeutics, Inc.

Completed

A Phase 2 Study to Evaluate Analgesic Effect of IV CR845 For Pain Following Bunionectomy Surgery

Acute Pain

United States
Casa di Cura Privata del Policlinico SpA

Recruiting

Transcranial Direct Current Stimulation and Dual Tasks (Tdcs&DT)

Parkinson Disease

Italy
Casa di Cura Privata del Policlinico SpA

Withdrawn

Validation of the Efficacy and Usability of the BELK Orthosis Knee Module in a Neurological Setting (BELK@CCP) (BELK@CCP)

Stroke | Central Nervous System Diseases | Neuromuscular Diseases | Knee Instability
Cara Medical Ltd

Recruiting

Cara CDRS (Conduction Disturbance Risk Score) 1.0 (CDRS)

Transcatheter Aortic Valve Replacement

Spain, Canada, Italy
Cara Medical Ltd

Recruiting

Cara CDRM (Conduction Disturbance Risk Monitor) 2.0 (Cara CDRM)

Transcatheter Aortic Valve Replacement

United States
Cara Therapeutics, Inc.

Recruiting

CR845-310302: A Study to Evaluate the Safety and Efficacy of Difelikefalin in Advanced Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus

Chronic Kidney Diseases | Pruritus

United States, Korea, Republic of, Australia, Bulgaria, Germany, Hungary, Italy, Poland, Romania, Spain, Argentina, Brazil, Mexico
Kura Oncology, Inc.

Recruiting

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

HNSCC

United States

Clinical Trials Sponsored by Mentis Cura

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations